idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
10/30/2019 08:32

Why Some Forms of Leukemia Only Affect Children

Iris Mickein Kommunikation & Marketing
Universität Basel

    Acute myeloid leukemia (AML) mainly affects children, with the prognosis often being poor despite several decades of research into more effective treatments. A new study led by researchers from the University of Basel and from Gustave Roussy Institute, Paris, explains why some forms of leukemia develop only in infants. The study also reveals potential new therapeutic targets, as the researchers report in the journal Cancer Discovery.

    Over recent decades, research into pediatric cancer has intensified and treatments have improved, but the prognosis remains particularly unfavorable for young patients. Acute myeloid leukemia (AML) accounts for 15% of cases of leukemia diagnosed in children and adolescents. Overall survival at age five is around 60%, with relapse being the most common cause of mortality.

    Abnormal protein fusion

    There are several subtypes of AML. One of the most aggressive types, which is linked to treatment resistance and a particularly unfavorable prognosis, is acute megakaryoblastic leukemia (AML-M7). It was on this particular form of leukemia that the research teams of Prof. Dr. Jürg Schwaller (University Children’s Hospital Basel and Department of Biomedicine at the University of Basel) and Prof. Dr. Thomas Mercher (INSERM U1170 at Gustave Roussy Institute, Université Paris Saclay) focused their attention.

    In 2012, the research team around Mercher found that AML-M7 frequently presents genetic alterations that lead to the expression of an abnormal protein resulting from the fusion of the two proteins normally independent in the cell. Although this fusion – known as ETO2-GLIS2 – has been identified in 30% of AML-M7 cases, the researchers had been unable to explain this abnormality. Similarly, it was unclear why children with AML-M7 are on average under age two while older children (on average towards the age of 6) are usually diagnosed with other pediatric AML subtypes.

    Targeted inhibition

    To address these questions, the researchers developed a mouse model of AML-M7 to study the expression of ETO2-GLIS2 fusion. In this model, the researchers could first show that the activation of ETO2-GLIS2 fusion in fetal hematopoietic cells is sufficient to rapidly induce aggressive leukemia – which is very similar to AML-M7. If, on the other hand, the fusion was activated in blood-forming cells of adult animals, this childhood leukemia did not occur, whereas other forms of AML developed much later. Moreover, by blocking ETO2-GLIS2 fusion in the in vivo model, researchers were able to bring tumor proliferation to a halt, with the abnormal blood cells once again able to differentiate into normal blood cells.

    These findings suggest that this particular type of leukemia only occurs in infants because fetal hematopoietic cells – unlike adult ones – are more sensitive to certain genetic mutations such as ETO2-GLIS2 fusion. The study also shows that ETO2-GLIS2 fusion is the actual motor of this form of pediatric leukemia. The researchers will now try to directly inhibit the activity of this fusion in the tumor cells.


    Contact for scientific information:

    Prof. Dr. Jürg Schwaller, Department of Biomedicine, University of Basel and University Children’s Hospital Basel, phone +41 61 265 35 17, email: j.schwaller@unibas.ch


    Original publication:

    Cécile K. Lopez et al.
    Ontogenic changes in hematopoietic hierarchy determine pediatric specificity and disease phenotype in fusion oncogene-driven myeloid leukemia
    Cancer Discovery (2019), doi: 10.1158/2159-8290.CD-18-1463

    https://cancerdiscovery.aacrjournals.org/content/early/2019/10/25/2159-8290.CD-1...


    Images

    Fusion gene in tumor cells: Red signals show the ETO2 gene locus, green signals the GLIS2 locus and yellow signals the ETO2-GLIS2 fusion.
    Fusion gene in tumor cells: Red signals show the ETO2 gene locus, green signals the GLIS2 locus and ...
    Chrystele Bilhou-Nabera & Nassera Abermil, Hôpital Saint Antoine, Paris.
    None


    Criteria of this press release:
    Journalists, Scientists and scholars, all interested persons
    Biology, Medicine
    transregional, national
    Research results, Scientific Publications
    English


     

    Fusion gene in tumor cells: Red signals show the ETO2 gene locus, green signals the GLIS2 locus and yellow signals the ETO2-GLIS2 fusion.


    For download

    x

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).